Exos Asset Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.32M Sell
4,554
-29
-0.6% -$8.43K 0.69% 47
2022
Q1
$1.34M Sell
4,583
-3,020
-40% -$875K 0.57% 56
2021
Q4
$2.19M Hold
7,603
1.13% 18
2021
Q3
$2.21M Buy
+7,603
New +$2.21M 1.17% 15

Other funds holding XAGE

Exos Asset Management's XAGE Position: Q2 2022 in Review

Exos Asset Management reduced its Longevity Health Holdings, Inc. Common Stock (XAGE) stake by 0.63% in Q2 2022, selling an estimated $8.43K and leaving 4,554 shares worth $1.32M. The position accounts for 0.69% of the portfolio, ranked #47.

Exos Asset Management first reported a position in XAGE in Q3 2021 and has held it in 4 quarters since. The position peaked at $2.21M in Q3 2021. 34 funds tracked by Wall St. Rank hold XAGE as of Q2 2022.

  • Exos Asset Management held 4,554 shares of Longevity Health Holdings, Inc. Common Stock worth $1.32M as of Q2 2022.
  • Exos Asset Management sold 29 Longevity Health Holdings, Inc. Common Stock shares in Q2 2022, an estimated $8.43K.
  • Longevity Health Holdings, Inc. Common Stock made up 0.69% of Exos Asset Management's portfolio in Q2 2022, its #47 holding.
  • Exos Asset Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and has held it in 4 quarters since.
  • Exos Asset Management's Longevity Health Holdings, Inc. Common Stock position peaked at $2.21M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.